Innovation. Advancement. Revolutionizing Healthcare.
At Gene Bio Medical, we are passionate about delivering innovative screening solutions focused on the prevention and early detection of diseases and inherited conditions. We specialize in developing cutting-edge molecular diagnostic tests that leverage the latest technologies to provide fast, accurate, and reliable results.
Our vision is to make high-quality testing solutions accessible to everyone, empowering individuals to detect and prevent potential health issues at an early stage. Guided by our mission to revolutionize healthcare, we strive to be a global leader in providing evidence-based, cost-effective, and reliable diagnostic solutions for communities worldwide.
Research and Development
Gene Bio Medical is a Canadian biotechnology and diagnostics company committed to advancing healthcare through innovation, scientific excellence, and scalable biomanufacturing.
We specialize in the research, development, and commercialization of molecular diagnostics, rapid point-of-care testing, infectious disease surveillance technologies, and AI-enabled healthcare solutions. Our multidisciplinary team works closely with academic institutions, healthcare providers, industry partners, and government organizations to transform scientific discoveries into real-world healthcare solutions.
During the COVID-19 pandemic, Gene Bio Medical played a significant role in supporting public health initiatives through the supply of millions of diagnostic tests and the expansion of domestic biomanufacturing capacity in Canada. Building on this experience, we continue to develop next-generation diagnostic platforms that improve accessibility, accuracy, and speed of testing across diverse healthcare settings.
Our research pipeline includes advanced molecular diagnostics, microfluidics, AI-assisted diagnostic technologies, digital health solutions, and novel disease detection platforms designed to address emerging global health challenges.
Fast. Reliable. Accurate.
These principles define our commitment to patients, healthcare professionals, and communities worldwide. As a forward-thinking organization, Gene Bio Medical is dedicated to strengthening healthcare resilience, expanding Canadian biomanufacturing capabilities, and delivering innovative technologies that help detect, prevent, and respond to future public health threats.
Through continuous innovation and strategic collaboration, we are shaping the future of diagnostics and contributing to a healthier, more sustainable world.
Growth Strategy
Gene Bio Medical has established a strong foundation supported by a robust intellectual property portfolio and a positive net present value. Our key competitive advantages include:
- Demonstrated technological feasibility
- A proven track record of financial performance
- Scalable manufacturing capabilities
- Active collaborations with ecosystem partners
- Strong unit economics
- Validated market demand through customer orders
Our growth strategy focuses on leveraging market trends and commercial insights, building strategic partnerships with innovators to accelerate commercialization, strengthening customer acquisition and retention, and advancing continuous localization initiatives.
We operate across the entire healthcare value chain, from raw material sourcing, research and development, and manufacturing to commercialization and global distribution.
Contract Manufacturing & Commercialization
Gene Bio Medical provides end-to-end manufacturing solutions for diagnostic reagents, rapid tests, and medical devices, including product development, technology transfer, quality management, regulatory compliance, packaging, and global commercialization support.
Regulatory & Licensing Consulting
Gene Bio Medical provides regulatory and licensing consulting services to support the successful development, approval, and commercialization of medical devices, in vitro diagnostics (IVDs), and healthcare technologies. Our team assists clients with regulatory strategy, Health Canada licensing, FDA submissions, ISO 13485 compliance, quality management systems, market access planning, and post-market regulatory support, helping innovators navigate complex regulatory pathways efficiently and confidently.
Regulatory Affairs & Licensing Consulting
- Health Canada
- FDA
- CE Mark
- ISO 13485
- MDSAP
- Medical Device Licensing
Our Mission
Our Commitment
Our Strength
We are committed to delivering transformative and innovative solutions that improve human health, strengthen disease response capabilities, and help prevent the global spread of infectious diseases.
We are dedicated to reinforcing the resilience of Canada’s biomanufacturing sector and medical supply chain while creating lasting economic and healthcare impacts across Canada.
As a women-led biotechnology company, Gene Bio Medical is committed to innovation, ESG principles, and sustainable growth. We empower women leaders in technology while developing disruptive solutions that advance healthcare and improve lives globally.
